Entering text into the input field will update the search result below

Ohr Pharmaceutical +82% on announcing merger with Neubase Therapeutics

  • Ohr Pharmaceutical (OHRP) is up 82% on entering into a merger agreement with NeuBase Therapeutics, under which the stockholders of NeuBase would become the majority holders of the combined company.
  • The combined company will change its name to “NeuBase Therapeutics, Inc.” and trading symbol on NASDAQ to “NBSE”.
  • Current Ohr and NeuBase stockholders will own ~20% and ~80% of the combined company, respectively.
  • The merger is subject to the approval of Ohr shareholders at a special meeting expected to occur in H1 2019.

Recommended For You

More Trending News

About NBSE Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
NBSE--
NeuBase Therapeutics, Inc.